Clinical Trial

Intravenous Antibiotic Treatment at Home

Study acronym: Hosp@Home

Recruiting

Record status

This record was last updated June 22, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Summary

The purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for the exchange of patient information, quality systems and procedures between the municipality and the hospital. This model will first be tested for use in intravenous antibiotic therapy. The results of the study will be used to further develop the service. In the larger context, it is desirable to provide knowledge that is transferable to other diagnostic groups, treatment methods and geographical areas.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2021-05-18; most recent amendment 2025-06-17.

Trial Details

NCT Number	NCT04898452
Lead Sponsor	Helse Møre og Romsdal HF Collaborators: SINTEF Health Research, Kristiansund municipality, Centre for Health Innovation, Hospital Pharmacy of Central Norway Trust
Conditions	Infection
Enrollment	50 participants
Start Date	2020-07-02
Primary Completion	2025-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-06-22